Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1962 2
1963 4
1964 5
1965 4
1966 3
1971 1
1972 4
1973 6
1974 1
1975 1
1976 2
1977 1
1978 1
1979 1
1981 1
1985 1
1986 3
1987 2
1988 4
1989 4
1990 4
1991 3
1992 10
1993 3
1995 3
1996 3
1997 2
1998 1
1999 6
2000 2
2001 5
2003 12
2004 6
2005 4
2006 6
2007 5
2008 1
2009 18
2010 7
2011 4
2012 6
2013 4
2014 12
2015 11
2016 7
2017 8
2018 15
2019 17
2020 14
2021 14
2022 12
2023 15
2024 18
2025 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Results by year

Filters applied: . Clear all
Page 1
Heterogeneity and transcriptional drivers of triple-negative breast cancer.
Jovanović B, Temko D, Stevens LE, Seehawer M, Fassl A, Murphy K, Anand J, Garza K, Gulvady A, Qiu X, Harper NW, Daniels VW, Xiao-Yun H, Ge JY, Alečković M, Pyrdol J, Hinohara K, Egri SB, Papanastasiou M, Vadhi R, Font-Tello A, Witwicki R, Peluffo G, Trinh A, Shu S, Diciaccio B, Ekram MB, Subedee A, Herbert ZT, Wucherpfennig KW, Letai AG, Jaffe JD, Sicinski P, Brown M, Dillon D, Long HW, Michor F, Polyak K. Jovanović B, et al. Among authors: anand j. Cell Rep. 2023 Dec 26;42(12):113564. doi: 10.1016/j.celrep.2023.113564. Epub 2023 Dec 14. Cell Rep. 2023. PMID: 38100350 Free PMC article.
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.
Shu S, Wu HJ, Ge JY, Zeid R, Harris IS, Jovanović B, Murphy K, Wang B, Qiu X, Endress JE, Reyes J, Lim K, Font-Tello A, Syamala S, Xiao T, Reddy Chilamakuri CS, Papachristou EK, D'Santos C, Anand J, Hinohara K, Li W, McDonald TO, Luoma A, Modiste RJ, Nguyen QD, Michel B, Cejas P, Kadoch C, Jaffe JD, Wucherpfennig KW, Qi J, Liu XS, Long H, Brown M, Carroll JS, Brugge JS, Bradner J, Michor F, Polyak K. Shu S, et al. Among authors: anand j. Mol Cell. 2020 Jun 18;78(6):1096-1113.e8. doi: 10.1016/j.molcel.2020.04.027. Epub 2020 May 15. Mol Cell. 2020. PMID: 32416067 Free PMC article.
Multifunctional Opioid Ligands.
Anand JP, Montgomery D. Anand JP, et al. Handb Exp Pharmacol. 2018;247:21-51. doi: 10.1007/164_2018_104. Handb Exp Pharmacol. 2018. PMID: 29675582 Review.
Breast cancer prevention by short-term inhibition of TGFβ signaling.
Alečković M, Cristea S, Gil Del Alcazar CR, Yan P, Ding L, Krop ED, Harper NW, Rojas Jimenez E, Lu D, Gulvady AC, Foidart P, Seehawer M, Diciaccio B, Murphy KC, Pyrdol J, Anand J, Garza K, Wucherpfennig KW, Tamimi RM, Michor F, Polyak K. Alečković M, et al. Among authors: anand j. Nat Commun. 2022 Dec 7;13(1):7558. doi: 10.1038/s41467-022-35043-5. Nat Commun. 2022. PMID: 36476730 Free PMC article.
PCNA-binding activity separates RNF168 functions in DNA replication and DNA double-stranded break signaling.
Yang Y, Jayaprakash D, Jhujh SS, Reynolds JJ, Chen S, Gao Y, Anand JR, Mutter-Rottmayer E, Ariel P, An J, Cheng X, Pearce KH, Blanchet SA, Nandakumar N, Zhou P, Fradet-Turcotte A, Stewart GS, Vaziri C. Yang Y, et al. Among authors: anand jr. Nucleic Acids Res. 2024 Nov 27;52(21):13019-13035. doi: 10.1093/nar/gkae918. Nucleic Acids Res. 2024. PMID: 39445802 Free PMC article.
Gursharan Singh Chhatwal.
Anand JK, Flachsbart F. Anand JK, et al. BMJ. 2017 May 22;357:j2504. doi: 10.1136/bmj.j2504. BMJ. 2017. PMID: 28533274 No abstract available.
Immunotherapeutics for AD: A Work in Progress.
Sharma A, Anand JS, Kumar Y. Sharma A, et al. Among authors: anand js. CNS Neurol Disord Drug Targets. 2022;21(9):752-765. doi: 10.2174/1871527320666210903101522. CNS Neurol Disord Drug Targets. 2022. PMID: 34477533 Review.
Hurler's syndrome.
Sharma NL, Singh RN, Anand JS. Sharma NL, et al. Among authors: anand js. Indian J Pediatr. 1965 Sep;32(212):301-6. doi: 10.1007/BF02756497. Indian J Pediatr. 1965. PMID: 4954514 No abstract available.
Inhibition of Androgen Receptor Exposes Replication Stress Vulnerability in Prostate Cancer.
Williams CS, Li X, Jang H, Anand JR, Lim WY, Lee H, Parks J, Zhang X, Xie J, Zhao J, Wu D, Armstrong AJ, Bowser JL, Zou L, Hong J, Somarelli JA, Vaziri C, Zhou P. Williams CS, et al. Among authors: anand jr. bioRxiv [Preprint]. 2024 Oct 11:2024.10.08.617102. doi: 10.1101/2024.10.08.617102. bioRxiv. 2024. PMID: 39416190 Free PMC article. Preprint.
306 results